Featured White Papers
- Enterprise PBX buyer's guide (VoIP-News)
- 5 Strategies for Making Sales the Engine for Growth (AchieveGlobal)
- Enterprise PBX comparison guide (VoIP-News)
Health Care Industry
Industry: Email Alert RSS FeedSystematic reviews provide more accurate assessments
American Family Physician, July 15, 2005 by Kenneth S. Fink
TO THE EDITOR: in her article, "omega-3 Fatty Acids," (1) in American Family Physician, Dr. Covington provides a thorough review of omega-3 fatty acids. A challenge for readers, however, is deciding how to change their practice based on a review. Reviews describe the included studies but often not their quality. In addition, the selection of references in a review may create a bias. These issues are addressed by performing a systematic review, which attempts to rigorously examine, evaluate, and synthesize all relevant studies on a given topic.
As one example of a different conclusion reached by a review and a systematic review, Dr. Covington described studies that reported improvement in patients with rheumatoid arthritis who take omega-3 fatty acids. However, a recent systematic review (2) found no significant improvement in pain, swollen joint count, or patient global assessment in those taking omega-3 fatty acids. This systematic review (2) was one of a series on omega-3 fatty acids developed by the Agency for healthcare research and Quality's evidence-based Practice Centers Program in partnership with the National institutes of health office of dietary Supplements. Reports also have been released on omega-3 fatty acids and other topics such as cardiovascular disease, cancer, type 2 diabetes, asthma, mental health, organ transplantation, and cognitive function. These can be accessed online at http:// www.ahrq.gov/clinic/epcix.htm. reports on maternal and child health and eye health care are in progress. Compared with narrative reviews, systematic reviews such as these can provide a more accurate assessment of the evidence for an intervention's safety and efficacy.
KENNETH S. FINK, M.D., M.G.A., M.P.H.
Director, Evidence-based Practice Centers Programs
Center for Outcomes and Evidence
Agency for Healthcare Research and Quality
540 Gaither Rd.
Rockville, MD 20850
REFERENCES
(1.) Covington MB. Omega-3 fatty acids. Am Fam Physician 2004;70:133-40.
(2.) Newberry SJ. Effects of omega-3 fatty acids on lipids and glycemic control in type II diabetes and the metabolic syndrome and on inflammatory bowel disease, rheumatoid arthritis, renal disease, systemic lupus erythematosus, and osteoporosis. Agency for Healthcare Research and Quality, U.S. Dept. of Health and Human Services, 2004. Rockville, Md.: Evidence report/technology assessment no. 89; AHCPR publication no. 04-E012-02.
EDITOR'S NOTE: this letter was sent to the author of "omega-3 Fatty Acids," who declined to reply.
COPYRIGHT 2005 American Academy of Family Physicians
COPYRIGHT 2008 Gale, Cengage Learning